Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06920992 · ClinicalTrials.gov registry record · NA

Cognitive Control Functions of the Human Thalamus

A NA study, sponsored by Kai Hwang.

Completed
Registry status
NA
Development phase
184
Enrollment target

NCT06920992 is a NA study that has completed, run by Kai Hwang. The registered enrollment target is 184 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06920992, a NA study, has completed, sponsored by Kai Hwang.

COMPLETED
Registry status
NA
Development phase
184 participants
Enrollment target

Study Summary

The goal of this research project is to investigate how brain lesions affect our ability to generate goal-directed behaviors - a cognitive function commonly referred to as cognitive control. To support goal-directed behaviors, the human brain must adaptively direct thoughts and actions depending on the current goals and contexts. Our principal hypothesis is that this cognitive capacity depends on a brain network architecture that can flexibly transmit, select, and inhibit information along neural pathways. Therefore, lesions and damages to critical brain network components will negatively affect behavior. To faithfully assess the structure and function of human brain networks and its disruption from brain lesions, investigators will recruit healthy adult human subjects and patients with brain lesions to participate in a multi-session study that includes cognitive behavioral tests, structural magnetic resonance imaging (MRI) using a 3 Tesla (3T) scanner, and electroencephalography (EEG) studies. During all testing sessions, subjects will perform cognitive tasks that assess their ability to select, maintain, and inhibit sensory information and generate motor responses. Their eye movements may be passively recorded during testings. 3T MRI allows for fast and high-resolution imaging of brain structures, enabling us to identify lesion loci. Investigators will use EEG to measure the electrophysiology of brain activities. All behavioral, EEG, and MRI data collected will be sent to the National Institute of Mental Health Data Archive (NDA) at the National Institute of Mental Health (NIMH).

Interventions

  • BEHAVIORAL Working memory and set-switching tasks

Trial Details

FieldValue
Enrollment Target 184 participants
Start Date 2020-03-10
Est. Completion 2025-12-31
Phase NA

Sponsor

Kai Hwang

2 total trials

What the Registry Record Tells You About NCT06920992

The ClinicalTrials.gov registry entry for NCT06920992 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 184 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Kai Hwang, which has 2 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Working memory and set-switching tasks is the first listed.

NCT06920992 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT06920992 about?

NCT06920992 is a clinical study titled "Cognitive Control Functions of the Human Thalamus". The goal of this research project is to investigate how brain lesions affect our ability to generate goal-directed behaviors - a cognitive function commonly referred to as cognitive control. To support goal-directed behaviors, the human brain must adaptively direct thoughts and actions depending on ...

What is the current status of trial NCT06920992?

This trial is currently completed. It is a NA study. The enrollment target is 184 participants. The study started on 2020-03-10. Estimated completion is 2025-12-31.

What interventions are being tested in trial NCT06920992?

The interventions under investigation include: Working memory and set-switching tasks (BEHAVIORAL).

Who is sponsoring clinical trial NCT06920992?

This trial is sponsored by Kai Hwang, which has 2 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.